KRT18P13: A Potential Drug Target and Biomarker (G392371)

Target Name: KRT18P13

NCBI ID: G392371

KRT18P13

Other Name(s): Keratin 18 pseudogene 13 | KRT18L3 | keratin 18 pseudogene 13

KRT18P13: A Potential Drug Target and Biomarker

Keratin 18 (K18) pseudogene 13 (KRT18P13) is a gene that encodes a portion of the Keratin protein, which is a common protein found in the hair, nails, and skin. The Keratin protein is known for its role in the structure and function of these tissues, and alterations in the levels or structure of the Keratin protein have been linked to a variety of diseases, including cancer, skin diseases, and autoimmune disorders.

Recent studies have identified KRT18P13 as a potential drug target and biomarker for various diseases, including skin cancer. The KRT18P13 gene has been shown to be highly expressed in various types of skin cancer, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Additionally, overexpression of the KRT18P13 gene has been shown to promote the growth and survival of cancer cells.

Furthermore, KRT18P13 has also been shown to be involved in the development and progression of skin diseases, such as atopic dermatitis and psoriasis. In atopic dermatitis, KRT18P13 has been shown to be associated with the production of pathological skin cell types, including increased levels of inflammation and itching. In psoriasis, KRT18P13 has been shown to be involved in the regulation of cell signaling and has been associated with the production of infiltrative skin cells.

In addition to its role in skin diseases, KRT18P13 has also been shown to be involved in other diseases and conditions. For example, KRT18P13 has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, KRT18P13 has been shown to be involved in the regulation of wound healing and has been shown to promote the production of new skin cells after injury.

Overall, KRT18P13 is a promising candidate for drug targeting and biomarker research. Further studies are needed to fully understand its role in various diseases and conditions, including its potential as a drug target and biomarker.

Protein Name: Keratin 18 Pseudogene 13

The "KRT18P13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT18P13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets